References
- June, K.M., K.J. Norton, V.W. Rees, and R.J. O'Connor: Influence of Measurement Setting and Home Smoking Policy on Smoking Topography; Addict. Behav. 37 (2012) 42–46. DOI:
https://doi.org/10.1016/j.addbeh.2011.07.039 - Cooperation Centre for Scientific Research Relative to Tobacco (CORESTA), Heated Tobacco Products Task Force: Technical Report - Heated Tobacco Products (HTPs): Standardized Terminology and Recommendations for the Generation and Collection of Emissions; CORESTA, Paris, France, 2020, pp. 11, available at:
https://www.coresta.org/heated-tobacco-products-htps-standardized-terminology-and-recommendations-generation-and-collection (accessed August 30, 2024). - Dempsey, R., G. Rodrigo, F. Vonmoos, I. Gunduz, M. Belushkin, and M. Esposito: Preliminary Toxicological Assessment of Heated Tobacco Products: A Review of the Literature and Proposed Strategy; Toxicol. Rep. 10 (2023) 195–205. DOI: 10.1016/j.toxrep.2023.01.008
- World Health Organization (WHO): Heated Tobacco Products: Information Sheet - 2nd Edition; WHO, Geneva, Switzerland, 2020, 11 pp., available at:
https://www.who.int/publications/i/item/WHO-HEP-HPR-2020.2 (accessed September 30, 2024). - McNeill, A., L.S. Brose, R. Calder, L. Bauld, and D. Robson: Evidence Review of E-Cigarettes and Heated Tobacco Products 2018: A Report Commissioned by Public Health England. 2018; Public Health England, London, UK, 2018, 243 pp.
- U.S. Food and Drug Administration (FDA): How Are Non-Combusted Cigarettes, Sometimes Called Heat-Not-Burn Products, Different from E-Cigarettes and Cigarettes?; FDA, available at:
https://www.fda.gov/tobacco-products/products-ingredients-components/how-are-non-combusted-cigarettes-sometimes-called-heat-not-burn-products-different-e-cigarettes-and (accessed August 30). - Proctor, C.: Assessment of Tobacco Heating Product THP1.0. Part 1: Series Introduction; Regul. Toxicol. Pharmacol. 93 (2018) 1–3. DOI: 10.1016/j.yrtph.2017.09.010
- Smith, M.R., B. Clark, F. Lüdicke, J.P. Schaller, P. Vanscheeuwijck, J. Hoeng, and M.C. Peitsch: Evaluation of the Tobacco Heating System 2.2. Part 1: Description of the System and the Scientific Assessment Program; Regul. Toxicol. Pharmacol. 81 Suppl 2 (2016) S17–S26. DOI: 10.1016/j.yrtph.2016.07.006
- Ichitsubo, H. and M. Kotaki: Indoor Air Quality (IAQ) Evaluation of a Novel Tobacco Vapor (NTV) Product; Regul. Toxicol. Pharmacol. 92 (2018) 278–294. DOI: 10.1016/j.yrtph.2017.12.017
- Simonavicius, E., A. McNeill, L. Shahab, and L.S. Brose: Heat-Not-Burn Tobacco Products: A Systematic Literature Review; Tob. Control 28 (2019) 582–594. DOI: 10.1136/tobaccocontrol-2018-054419
- Cooperation Centre for Scientific Research Relative to Tobacco (CORESTA), E-Cigarette Task Force, C. Garner, and R. Stevens: Reference Report - A Brief Description of History, Operation and Regulation, February 2014; CORESTA, Paris, France, 2014, pp. 12, available at:
https://www.coresta.org/e-cigarettes-brief-description-history-operation-and-regulation-29234.html (accessed August 30, 2024). - AFNOR: XP D90-300-3: Electronic Cigarettes and E-Liquids - Part 3: Requirements and Test Methods for Emissions; AFNOR, Saint-Denis, France, 2016.
- European Center for Standardisation (CEN): CEN/TS 17287:2019 - Requirements and Test Methods for Electronic Cigarette Devices; CEN, Brussels, Belgium, 2019.
- U.S. Centers for Disease Control and Prevention (CDC): Website - E-Cigarettes (Vapes); CDC, available at:
https://www.cdc.gov/tobacco/e-cigarettes/?CDC_AAref_Val=https://www.cdc.gov/tobacco/basic_information/e-cigarettes/index.htm (accessed September 30, 2024). - International Organization for Standardization (ISO): ISO 20768:2018 - Vapour Products - Routine Analytical Vaping Machine - Definitions and Standard Conditions; ISO, Geneva, Switzerland, 2018.
- World Health Organization (WHO): Website - Electronic Nicotine Delivery Systems and Electronic Non-Nicotine Delivery Systems (ENDS/ENNDS); WHO, Geneva, Switzerland, last updated January 25, 2017, available at:
https://www.who.int/news/item/25-01-2017-electronic-nicotine-delivery-systems-and-electronic-non-nicotine-delivery-systems-(ends-ennds ) (accessed September 30, 2024). - U.S. Food and Drug Administration (FDA): Website - E-Cigarettes, Vapes, and Other Electronic Nicotine Delivery Systems (ENDS); last updated May 31, 2024, available at:
https://www.fda.gov/tobacco-products/products-ingredients-components/e-cigarettes-vapes-and-other-electronic-nicotine-delivery-systems-ends (accessed August 30). - Cooperation Centre for Scientific Research Relative to Tobacco (CORESTA), Tobacco and Tobacco Products Analytes Sub-Group, K. Wagner, F. Aldeek, and M. Morton: Technical Report. 2020 Nicotine and Nicotine Degradants Proficiency Study; CORESTA, Paris, France, September 2020, 2020, 62 pp., available at:
https://www.coresta.org/2020-nicotine-and-nicotine-degradants-proficiency-study-34035.html (accessed September 11, 2024). - Swedish Institute for Standards (SIS): SIS/TS 72:2020 — Nicotine-Containing, Tobacco-Free Oral Products — Safety and Quality Related Requirements; SIS, Stockholm, Sweden, 2020.
- British American Tobacco: Website - Product categories — Modern oral products, available at:
https://www.bat.com/brands-and-innovation/product-categories/modern-oral-products (accessed October 02, 2024). - Imperial Brands: Website - Commentary: The Tobacco-Free Nicotine Pouch Opportunity; Imperial Brands, Bristol, UK, last updated Dec 10, 2020, available at:
https://imperialbrandsscience.com/time-line/commentary-the-tobacco-free-nicotine-pouch-opportunity/ (accessed September 06, 2024). - Baker, R.R., M. Dixon, D.C. Mariner, C.J. Shepperd, G. Scherer, M.W. Ogden, J.H. Robinson, N.M. Sinclair, N. Sherwood, Y. Akiyama, K. Sakamoto, W. Röper, A.R. Tricker, V. Marchand, B. Varignon, and G. Lionetti: Seminars in Tobacco Science: Terms Used for Exposure to Smoke; Beitr. Tabakforsch. Int. 21 (2004) 250. DOI: 10.2478/cttr-2013-0787
- Gregg, E., T. Bachmann, R. Bito, X. Cahours, M. McEwan, P. Nelson, K. Prasad, G. Scherer, and M. Stiles: Assessing Smoking Behaviour and Tobacco Smoke Exposure: Definitions and Methods; Beitr. Tabakforsch. Int. 25 (2013) 685–699. DOI: 10.2478/cttr-2013-0945
- Corrigan, P.W. and A.C. Watson: Understanding the Impact of Stigma on People with Mental Illness; World Psychiatry 1 (2002) 16–20.
- Volkow, N.D., J.A. Gordon, and G.F. Koob: Choosing Appropriate Language to Reduce the Stigma Around Mental Illness and Substance Use Disorders; Neuropsychopharmacology 46 (2021) 2230–2232. DOI: 10.1038/s41386-021-01069-4
- Williamson, T.J., K.E. Riley, L. Carter-Harris, and J.S. Ostroff: Changing the Language of How We Measure and Report Smoking Status: Implications for Reducing Stigma, Restoring Dignity, and Improving the Precision of Scientific Communication; Nicotine Tob. Res. 22 (2020) 2280–2282. DOI: 10.1093/ntr/ntaa141
- Centers for Disease Control and Prevention (CDC): Website - National Health Interview Survey - Glossary; CDC, Atlanta, GA, USA, last updated August 29, 2017, available at:
https://www.cdc.gov/nchs/nhis/tobacco/tobacco_glossary.htm (accessed September 06, 2024). - Centers for Disease Control and Prevention (CDC): Website - National Health Interview Survey - Smoking Status Recodes; CDC, Atlanta, GA, USA, last updated August 29, 2017, available at:
https://www.cdc.gov/nchs/nhis/tobacco/tobacco_recodes.htm (accessed September 06, 2024). - Substance Abuse and Mental Health Services Administration (SAMHSA): Key Substance Use and Mental Health Indicators in the United States: Results from the 2019 National Survey on Drug Use and Health; SAMHSA, Rockville, MD, USA, 2020, No. PEP20-07-01-001, available at:
https://www.samhsa.gov/data/sites/default/files/reports/rpt29393/2019NSDUHFFRPDFWHTML/2019NSDUHFFR1PDFW090120.pdf (accessed September 06, 2024). - World Health Organization (WHO): Guidelines for Controlling and Monitoring the Tobacco Epidemic; WHO, Geneva, Switzerland, 1998, X+190 pp. ISBN: 92-4-154508-9, available at:
https://apps.who.int/iris/handle/10665/42049 (accessed September 06, 2024). - National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA), and U.S. Food and Drug Administration (FDA): Website - PATH - Population Assessment of Tobacco and Health; last updated Jan 03, 2024, available at:
https://pathstudyinfo.nih.gov/landing (accessed September 06, 2024). - Johnson, S.E., E. Holder-Hayes, G.K. Tessman, B.A. King, T. Alexander, and X. Zhao: Tobacco Product Use among Sexual Minority Adults: Findings from the 2012–2013 National Adult Tobacco Survey; Am. J. Prev. Med. 50 (2016) e91–e100. DOI: 10.1016/j.amepre.2015.07.041
- Agaku, I.T., A.J. Awopegba, and F.T. Filippidis: The Impact of Inter-Survey Differences in the Definition of Current Smokeless Tobacco Use on Comparability of US National and State-Specific Prevalence Estimates, 2009–2011; Prev. Med. 74 (2015) 86–92. DOI:
https://doi.org/10.1016/j.ypmed.2015.01.014 - Agaku, I.T., B.A. King, C.G. Husten, R. Bunnell, B.K. Ambrose, S.S. Hu, E. Holder-Hayes, and H.R. Day: Tobacco Product Use among Adults - United States, 2012–2013; Morb. Mortal. Wkly. Rep. 63 (2014) 542–547.
- Aljandaleh, H., C. Bolze, F. El-Khoury Lesueur, M. Melchior, and M. Mary-Krause: Factors Associated with Electronic Cigarette Use among Young Adults: The French “Trajectoires EpidéMiologiques En POpulation” (TEMPO) Cohort Study; Subst. Use Misuse 55 (2020) 964–972. DOI: 10.1080/10826084.2020.1717534
- Andrews, J.A., S.E. Hampson, H.H. Severson, E. Westling, and M. Peterson: Perceptions and Use of E-Cigarettes Across Time among Emerging Adults; Tob. Regul. Sci. 2 (2016) 70–81. DOI: 10.18001/trs.2.1.8
- Chen, D.T.-H., C. Girvalaki, E.A. Mechili, C. Millett, and F.T. Filippidis: Global Patterns and Prevalence of Dual and Poly-Tobacco Use: A Systematic Review; Nicotine Tob. Res. 23 (2021) 1816–1820. DOI: 10.1093/ntr/ntab084
- Rubenstein, D., L.R. Pacek, and F.J. McClernon: Multiple Tobacco Product Use Conceptual Framework: A 2021 Update on Evidence; Nicotine Tob. Res. 24 (2022) 1208–1217. DOI: 10.1093/ntr/ntac032
- European Commission: Special Eurobarometer 506. Report. Attitudes of Europeans Towards Tobacco and Electronic Cigarettes. August-September 2020; 2021, available at:
https://www.drugsandalcohol.ie/33761/1/Eurobarometer_2020_cigarettes_ebs_506.pdf (accessed September 06, 2024). DOI: 10.2875/490366 - Brouwer, A.F., J. Jeon, J.L. Hirschtick, E. Jimenez-Mendoza, R. Mistry, I.V. Bondarenko, S.R. Land, T.R. Holford, D.T. Levy, J.M.G. Taylor, N.L. Fleischer, and R. Meza: Transitions between Cigarette, ENDS and Dual Use in Adults in the PATH Study (Waves 1–4): Multistate Transition Modelling Accounting for Complex Survey Design; Tob. Control 31 (2022) 424–431. DOI: 10.1136/tobaccocontrol-2020-055967
- Chen DT, Girvalaki C, Mechili EA, et al. (2021). Global Patterns and Prevalence of Dual and Poly-Tobacco Use: A Systematic Review. Nicotine & tobacco research: official journal of the Society for Research on Nicotine and Tobacco, 23(11), 1816–1820.
- Lin, J., K. Zhu, A.M. Soliván-Ortiz, S.L. Larsen, S.P. Irwin, T.R. Schneid, C.D. Shriver, and S. Lee: Dual Use of Cigarettes and Smokeless Tobacco Among Active Duty Service Members in the US Military; Mil. Psychol. 34 (2021) 432–444. DOI: 10.1080/08995605.2021.2004046
- Coleman, S.R.M., M.E. Piper, M.J. Byron, and K.W. Bold: Dual Use of Combustible Cigarettes and E-Cigarettes: A Narrative Review of Current Evidence; Curr. Addict. Rep. 9 (2022) 353–362. DOI: 10.1007/s40429-022-00448-1
- Borland, R., K. Murray, S. Gravely, G.T. Fong, M.E. Thompson, A. McNeill, R.J. O'Connor, M.L. Goniewicz, H.-H. Yong, D.T. Levy, B.W. Heckman, and K.M. Cummings: A New Classification System for Describing Concurrent Use of Nicotine Vaping Products Alongside Cigarettes (So-Called ‘Dual Use’): Findings from the ITC-4 Country Smoking and Vaping Wave 1 Survey; Addiction 114 (2019) 24–34. DOI: 10.1111/add.14570
- Rodenstein, D.O. and D.C. Stanescu: Pattern of Inhalation of Tobacco Smoke in Pipe, Cigarette, and Never Smokers; Am. Rev. Respir. Dis. 132 (1985) 628–632. DOI: 10.1164/arrd.1985.132.3.628
- Baker, R.R. and M. Dixon: The Retention of Tobacco Smoke Constituents in the Human Respiratory Tract; Inhal. Toxicol. 18 (2006) 255–294. DOI: 10.1080/08958370500444163
- Dickens, C., C. McGrath, N. Warren, P. Biggs, and J. McAughey: Puffing and Inhalation Behaviour in Cigarette Smoking: Implications for Particle Diameter and Dose; J. Phys. Conf. Ser. 151 (2009) 012019. DOI: 10.1088/1742-6596/151/1/012019
- Mikheev, V.B., S.S. Buehler, M.C. Brinkman, C.A. Granville, T.E. Lane, A. Ivanov, K.M. Cross, and P.I. Clark: The Application of Commercially Available Mobile Cigarette Topography Devices for E-Cigarette Vaping Behavior Measurements; Nicotine Tob. Res. 22 (2020) 681–688. DOI: 10.1093/ntr/nty190
- Robinson, R.J., S.E. Sarles, S. Jayasekera, A. al Olayan, A.G. Difrancesco, N.C. Eddingsaas, and E.C. Hensel: A Comparison between Cigarette Topography from a One-Week Natural Environment Study to FTC/ISO, Health Canada, and Massachusetts Department of Public Health Puff Profile Standards; Int. J. Environ. Res. Public Health 17 (2020) 3444. DOI: 10.3390/ijerph17103444
- Wadkin, R., C. Allen, and I.M. Fearon: E-Cigarette Puffing Topography: The Importance of Assessing User Behaviour to Inform Emissions Testing; Drug Testing and Analysis 15 (2023) 1222–1232. DOI: 10.1002/dta.3322
- Soule, E., M. Bansal-Travers, R. Grana, S. McIntosh, S. Price, J.B. Unger, and K. Walton: Electronic Cigarette Use Intensity Measurement Challenges and Regulatory Implications; Tob. Control 32 (2023) 124–129. DOI: 10.1136/tobaccocontrol-2021-056483
- Dowd, A.N., L. John, J.M. Betts, P. Belsare, E. Sazonov, and S.T. Tiffany: An Examination of Objective and Self-Report Measures of Ad Libitum Electronic Cigarette Use: Identifying Patterns of Puffing Behavior and Evaluating Self-Report Items; Nicotine Tob. Res. 25 (2023) 1391–1399. DOI: 10.1093/ntr/ntad037
- Gao, X., M. Fewx, J. Sprock, H. Jiang, Y. Gao, and Y. Liu: A Novel Puff Recording Electronic Nicotine Delivery System for Assessing Naturalistic Puff Topography and Nicotine Consumption During Ad Libitum Use: Ancillary Study; JMIR Form. Res. 7 (2023) e42544. DOI: 10.2196/42544
- Gao, X., L. Humberstone, and Y. Liu: Actual Use Behavior Assessment of a Novel Puff Recording Electronic Nicotine Delivery System: Observation Study; JMIR Form. Res. 7 (2023) e43175. DOI: 10.2196/43175
- Underly, R., G.M. Dull, E. Nudi, T. Pionk, K. Prevette, and J. Smith: Using a Novel Connected Device for the Collection of Puffing Topography Data for the Vuse Solo Electronic Nicotine Delivery System in a Real-World Setting: Prospective Ambulatory Clinical Study; JMIR Form. Res. 7 (2023) e49876. DOI: 10.2196/49876
- Marian, C., R.J. O'Connor, M.V. Djordjevic, V.W. Rees, D.K. Hatsukami, and P.G. Shields: Reconciling Human Smoking Behavior and Machine Smoking Patterns: Implications for Understanding Smoking Behavior and the Impact on Laboratory Studies; Cancer Epidemiol. Biomarkers Prev. 18 (2009) 3305–3320. DOI: 10.1158/1055-9965.Epi-09-1014
- Bernstein, D.: A Review of the Influence of Particle Size, Puff Volume, and Inhalation Pattern on the Deposition of Cigarette Smoke Particles in the Respiratory Tract; Inhal. Toxicol. 16 (2004) 675–689. DOI: 10.1080/08958370490476587
- St. Charles, F.K., G.R. Krautter, and D.C. Mariner: Post-Puff Respiration Measures on Smokers of Different Tar Yield Cigarettes; Inhal. Toxicol. 21 (2009) 712–718. DOI: 10.1080/08958370802353443
- Creighton, D., M.J. Noble, and R. Whewell: Instruments to Measure, Record and Duplicate Human Smoking Patterns; in: Smoking Behaviour: Physiological and Psychological Influences, Proc. International Smoking Behaviour Conference, 1977, Chelwood Vachery, UK, edited by R.E. Thornton, Churchill Livingstone, London, UK, 1978, pp. 277–288. ISBN: 978-0443018152.
- World Health Organization (WHO): International Programme on Chemical Safety. IPCS Risk Assessment Terminology; WHO, Geneva, Switzerland, 2004, 117 pp., available at:
https://www.who.int/publications/i/item/9241562676 (accessed September 06, 2024). - World Health Organization (WHO): Characterization and Application of Physiologically Based Pharmacokinetic Models in Risk Assessment; WHO, Geneva, Switzerland, 2010, 97 pp., ISBN: 9241562676, available at:
https://www.who.int/publications/i/item/9789241500906 (accessed September 06, 2024). - Armitage, A.K., M. Dixon, B.E. Frost, D.C. Mariner, and N.M. Sinclair: The Effect of Tobacco Blend Additives on the Retention of Nicotine and Solanesol in the Human Respiratory Tract and on Subsequent Plasma Nicotine Concentrations During Cigarette Smoking; Chem. Res. Toxicol. 17 (2004) 537–544. DOI: 10.1021/tx0340753
- O'Connell, G., S. Colard, K. Breiev, P. Sulzer, S.S. Biel, X. Cahours, J.D. Pritchard, and K.M. Burseg: An Experimental Method to Determine the Concentration of Nicotine in Exhaled Breath and its Retention Rate Following Use of an Electronic Cigarette; J. Environ. Anal. Chem. 2 (2015) 1000161. DOI: 10.4172/2380-2391.1000161
- Healthy London Partnership: Nicotine Pouch User Guide, available at:
https://www.healthylondon.org/wp-content/uploads/2020/06/Nicotine-Pouch-User-Guide_HDAS-London.pdf (accessed September 11, 2024). - Lunell, E., K. Fagerström, J. Hughes, and R. Pendrill: Pharmacokinetic Comparison of a Novel Non-Tobacco-Based Nicotine Pouch (ZYN) with Conventional, Tobacco-Based Swedish Snus and American Moist Snuff; Nicotine Tob. Res. 22 (2020) 1757–1763. DOI: 10.1093/ntr/ntaa068
- McEwan, M., D. Azzopardi, N. Gale, O.M. Camacho, G. Hardie, I.M. Fearon, and J. Murphy: A Randomised Study to Investigate the Nicotine Pharmacokinetics of Oral Nicotine Pouches and a Combustible Cigarette; Eur. J. Drug Metab. Pharmacokinetics 47 (2021) 211–221. DOI: 10.1007/s13318-021-00742-9
- Azzopardi, D., C. Liu, and J. Murphy: Chemical Characterization of Tobacco-Free “Modern” Oral Nicotine Pouches and Their Position on the Toxicant and Risk Continuums; Drug Chem. Toxicol. 45 (2021) 2246–2254. DOI: 10.1080/01480545.2021.1925691
- Scherer, G.: Suitability of Biomarkers of Biological Effects (BOBEs) for Assessing the Likelihood of Reducing the Tobacco Related Disease Risk by New and Innovative Tobacco Products: A Literature Review; Regul. Toxicol. Pharmacol. 94 (2018) 203–233. DOI: 10.1016/j.yrtph.2018.02.002
- Chang, C.M., S.H. Edwards, A. Arab, A.Y. Del Valle-Pinero, L. Yang, and D.K. Hatsukami: Biomarkers of Tobacco Exposure: Summary of an FDA-Sponsored Public Workshop; Cancer Epidemiol. Biomarkers Prev. 26 (2017) 291–302. DOI: 10.1158/1055-9965.EPI-16-0675
- Chang, C.M., Y.-C. Cheng, T.M. Cho, E.V. Mishina, A.Y. Del Valle-Pinero, D.M. van Bemmel, and D.K. Hatsukami: Biomarkers of Potential Harm: Summary of an FDA-Sponsored Public Workshop; Nicotine Tob. Res. 21 (2019) 3–13. DOI: 10.1093/ntr/ntx273
- Institute of Medicine (IOM): Clearing the Smoke: Assessing the Science Base for Tobacco Harm Reduction; edited by K. Stratton, P. Shetty, R. Wallace, et al., National Academies Press, Washington, DC, USA, 2001, 636 pp. ISBN: 978-0-309-07282-3. DOI: 10.17226/10029
- Drovandi, A., S. Salem, D. Barker, D. Booth, and T. Kairuz: Human Biomarker Exposure from Cigarettes Versus Novel Heat-Not-Burn Devices: A Systematic Review and Meta-Analysis; Nicotine Tob. Res. 22 (2020) 1077–1085. DOI: 10.1093/ntr/ntz200
- Akiyama, Y. and N. Sherwood: Systematic Review of Biomarker Findings from Clinical Studies of Electronic Cigarettes and Heated Tobacco Products; Toxicol. Rep. 8 (2021) 282–294. DOI: 10.1016/j.toxrep.2021.01.014
- Tran, C.T., M. Bosilkovska, G. de La Bourdonnaye, N. Blanc, and C. Haziza: Reduced Levels of Biomarkers of Exposure in Smokers Switching to the Carbon-Heated Tobacco Product 1.0: A Controlled, Randomized, Open-Label 5-Day Exposure Trial; Sci. Rep. 10 (2020) 19227. DOI: 10.1038/s41598-020-76222-y
- Haziza, C., G. de La Bourdonnaye, A. Donelli, V. Poux, D. Skiada, R. Weitkunat, G. Baker, P. Picavet, and F. Lüdicke: Reduction in Exposure to Selected Harmful and Potentially Harmful Constituents Approaching Those Observed Upon Smoking Abstinence in Smokers Switching to the Menthol Tobacco Heating System 2.2 for 3 Months (Part 1); Nicotine Tob. Res. 22 (2020) 539548. DOI: 10.1093/ntr/ntz013
- Miura, N., D. Yuki, N. Minami, A. Kakehi, and Y. Futamura: A Study to Investigate Changes in the Levels of Biomarkers of Exposure to Selected Cigarette Smoke Constituents in Japanese Adult Male Smokers Who Switched to a Non-Combustion Inhaler Type of Tobacco Product; Regul. Toxicol. Pharmacol. 71 (2015) 498–506. DOI: 10.1016/j.yrtph.2015.02.007
- Round, E.K., P. Chen, A.K. Taylor, and E. Schmidt: Biomarkers of Tobacco Exposure Decrease after Smokers Switch to an E-Cigarette or Nicotine Gum; Nicotine Tob. Res. 21 (2019) 1239–1247. DOI: 10.1093/ntr/nty140
- International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH): ICH Harmonised Guideline - Bioanalytical Method Validation and Study Sample Analysis - M10. Final Version - Adopted on 24 May 2022; ICH, Geneva, Switzerland, 2022, 59 pp.
- U.S. Department of Health and Human Services (DHHS), Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), and Center for Biologics Evaluation and Research (CBER): M10 Bioanalytical Method Validation and Study Sample Analysis. Guidance for Industry; ICH, Geneva, Switzerland, 2022, 50 pp.
- European Medicines Agency (EMA): ICH Guideline M10 on Bioanalytical Method Validation and Study Sample Analysis. Step5; Ref. No. EMA/CHMP/ICH/172948/2019, Amsterdam, The Netherlands, 2022, 45 pp.
- Cooperation Centre for Scientific Research Relative to Tobacco (CORESTA), Biomarkers Sub-Group: CORESTA Guide No. 20. Biomarker Studies — Requirements for the Certification of Analytical Reference Standards; 2nd ed., CORESTA, Paris, France, 2021, 8 pp., available at:
https://www.coresta.org/biomarker-studies-requirements-certificationanalytical-reference-standards-35006.html (accessed September 06, 2024). - Heavner, D.L., W.T. Morgan, S.B. Sears, J.D. Richardson, G.D. Byrd, and M.W. Ogden: Effect of Creatinine and Specific Gravity Normalization Techniques on Xenobiotic Biomarkers in Smokers' Spot and 24-h Urines; J. Pharm. Biomed. Anal. 40 (2006) 928–942. DOI: 10.1016/j.jpba.2005.08.008
- Sarkar, M., R. Muhammad-Kah, Q. Liang, S. Kapur, S. Feng, and H. Roethig: Evaluation of Spot Urine as an Alternative to 24h Urine Collection for Determination of Biomarkers of Exposure to Cigarette Smoke in Adult Smokers; Environ. Toxicol. Pharmacol. 36 (2013) 108–114. DOI: 10.1016/j.etap.2013.03.001
- Lermen, D., M. Bartel-Steinbach, F. Gwinner, A. Conrad, T. Weber, H. von Briesen, and M. Kolossa-Gehring: Trends in Characteristics of 24-h Urine Samples and Their Relevance for Human Biomonitoring Studies – 20 Years of Experience in the German Environmental Specimen Bank; Int. J. Hyg. Environ. Health 222 (2019) 831–839. DOI:
https://doi.org/10.1016/j.ijheh.2019.04.009 - U.S. Department of Health and Human Services (DHHS), Food and Drug Administration (FDA), Center for Tobacco Products (CTP): Guidance for Industry - Modified Risk Tobacco Product Applications - Draft Guidance; DHHS, Rockville, MD, USA, 2012.
- U.S. Department of Health and Human Services (DHHS), Food and Drug Administration (FDA), Center for Tobacco Products (CTP): Guidance for Industry. Reporting Harmful and Potentially Harmful Constituents in Tobacco Products and Tobacco Smoke under Section 904(a)(3) of the Federal Food, Drug, and Cosmetic Act. Draft Guidance; DHHS, Silver Spring, MD, USA, 2012, 10 pp.
- World Health Organization (WHO): The Scientific Basis of Tobacco Product Regulation. Second Report of a WHO Study Group; WHO Technical Report Series, Vol. 951, WHO, Geneva, Switzerland, 2008, 277 pp. ISBN: 978 92 4 120951 9.
- Landmesser, A., M. Scherer, N. Pluym, M. Sarkar, J. Edmiston, R. Niessner, and G. Scherer: Biomarkers of Exposure Specific to E-Vapor Products Based on Stable-Isotope Labeled Ingredients; Nicotine Tob. Res. 21 (2019) 314–322. DOI: 10.1093/ntr/nty204
- Institute of Medicine (IOM): Scientific Standards for Studies on Modified Risk Tobacco Products; National Academies Press, Washington, DC, USA, 2012, 350 pp. ISBN: 978-0-309-22398-0, available at:
http://www.nap.edu/download.php?record_id=13294 (accessed September 11, 2024). - World Health Organization (WHO): The Scientific Basis of Tobacco Product Regulation. Report of a WHO Study Group; WHO Technical Report Series, Vol. 945, WHO, 2007, 112 pp. ISBN: 9241209453.
- Forey, B.A., A.J. Thornton, and P.N. Lee: Systematic Review with Meta-Analysis of the Epidemiological Evidence Relating Smoking to COPD, Chronic Bronchitis and Emphysema; BMC Pulm. Med. 11 (2011) 36. DOI: 10.1186/1471-2466-11-36
- U.S. Department of Health and Human Services (DHHS), Centers for Disease Control and Prevention (CDC), National Center for Chronic Disease Prevention and Health Promotion, and Office on Smoking and Health: The Health Consequences of Smoking: A Report of the Surgeon General; DHHS, Washington, DC, USA, 2004, 910 pp. ISBN: 0-16-051576-2.
- Benjamin, E.J., M.J. Blaha, S.E. Chiuve, M. Cushman, S.R. Das, R. Deo, S.D. de Ferranti, J. Floyd, M. Fornage, C. Gillespie, C.R. Isasi, M.C. Jiménez, L.C. Jordan, S.E. Judd, D. Lackland, J.H. Lichtman, L. Lisabeth, S. Liu, C.T. Longenecker, R.H. Mackey, et al.: Heart Disease and Stroke Statistics - 2017 Update: A Report from the American Heart Association; Circulation 135 (2017) e146–e603. DOI: 10.1161/CIR.0000000000000485
- U.S. Department of Health and Human Services (DHHS): How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease : A Report of the Surgeon General; DHHS, Rockville, MD, USA, 2010, 722 pp. ISBN: 978-0-16-084078-4, available at:
https://www.ncbi.nlm.nih.gov/books/NBK53017/ . - Cooperation Centre for Scientific Research Relative to Tobacco (CORESTA), Biomarkers Sub-Group: Technical Report. Review of Recent Lung Biomarkers of Potential Harm/Effect for Tobacco Research; CORESTA, Paris, France, 2020, 29 pp., available at:
https://www.coresta.org/review-recent-lung-biomarkers-potential-harmeffect-tobacco-research-34041.html (accessed September 11, 2024). - Aherrera, A., A. Aravindakshan, S. Jarmul, P. Olmedo, R. Chen, J.E. Cohen, A. Navas-Acien, and A.M. Rule: E-Cigarette Use Behaviors and Device Characteristics of Daily Exclusive E-Cigarette Users in Maryland: Implications for Product Toxicity; Tob. Induc. Dis. 18 (2020) 93. DOI: 10.18332/tid/128319
- Clarke, E., K. Thompson, S. Weaver, J. Thompson, and G. O'Connell: Snus: A Compelling Harm Reduction Alternative to Cigarettes; Harm Reduct. J. 16 (2019) 62. DOI: 10.1186/s12954-019-0335-1
- Peto, J.: That the Effects of Smoking Should Be Measured in Pack-Years: Misconceptions 4; Br. J. Cancer 107 (2012) 406–407. DOI: 10.1038/bjc.2012.97
- Burling, T.A., M.L. Stitzer, G.E. Bigelow, and A.M. Mead: Smoking Topography and Carbon Monoxide Levels in Smokers; Addict. Behav. 10 (1985) 319–323. DOI:
https://doi.org/10.1016/0306-4603(85)90014-0 - Hamabe, A., H. Uto, Y. Imamura, K. Kusano, S. Mawatari, K. Kumagai, T. Kure, T. Tamai, A. Moriuchi, T. Sakiyama, M. Oketani, A. Ido, and H. Tsubouchi: Impact of Cigarette Smoking on Onset of Nonalcoholic Fatty Liver Disease over a 10-Year Period; Journal of Gastroenterology 46 (2011) 769–778. DOI: 10.1007/s00535-011-0376-z
- Bernaards, C.M., J.W.R. Twisk, J. Snel, W. Van Mechelen, and H.C.G. Kemper: Is Calculating Pack-Years Retrospectively a Valid Method to Estimate Life-Time Tobacco Smoking? A Comparison between Prospectively Calculated Pack-Years and Retrospectively Calculated Pack-Years; Addiction 96 (2001) 1653–1661. DOI: 10.1046/j.1360-0443.2001.9611165311.x
- International Organization for Standardization (ISO): ISO 3308:2012 - Routine Analytical Cigarette-Smoking Machine-Definitions and Standard Conditions; ISO, Geneva, Switzerland, 2012.
- Health Canada, Tobacco Control Programme: Determination of “Tar”, Nicotine and Carbon Monoxide in Mainstream Tobacco Smoke; Health Canada, Ottawa, ON, Canada, 1999, 7 pp., Official Method T-115.
- International Organization for Standardization (ISO): ISO 20778:2018 - Cigarettes - Routine Analytical Cigarette Smoking Machine - Definitions and Standard Conditions with an Intense Smoking Regime; ISO, Geneva, Switzerland, 2018.
- Ashley, M., A. Sisodiya, M. McEwan, J. McAughey, and K. Prasad: Comparison of Mouth Level Exposure to ‘Tar’ and Nicotine in Smokers of Normal and Superslim King Size Cigarettes in Romania; Beitr. Tabakforsch. Int. 24 (2011) 277–288. DOI: 10.2478/cttr-2013-0908106
- Reilly, S.M., R. Goel, Z. Bitzer, R.J. Elias, J. Foulds, J. Muscat, and J.P. Richie Jr: Effects of Topography-Related Puff Parameters on Carbonyl Delivery in Mainstream Cigarette Smoke; Chem. Res. Toxicol. 30 (2017) 1463–1469. DOI: 10.1021/acs.chemrestox.7b00104
- Sussman, R.A., F. Sipala, R. Emma, and S. Ronsisvalle: Aerosol Emissions from Heated Tobacco Products: A Review Focusing on Carbonyls, Analytical Methods, and Experimental Quality; Toxics 11 (2023) 947. DOI: 10.3390/toxics11120947
- Gupta, A., R. Tayyarah, G. Gillman, C. Garner, and R. Stevens: Machine Vaping of Electronic Cigarettes - A Comparison of Puffing Regimes; Contrib. Tob. Nicotine Res. 30 (2021) 127–136. DOI: 10.2478/cttr-2021-0009
- Vas, C.A., C.Ü. Yurteri, C.J. Dickens, and K. Prasad: Development and Characterisation of a Smoking Behaviour Measurement System; Beitr. Tabakforsch. Int. 26 (2015) 219–231. DOI: 10.1515/cttr-2015-0010
- McEwan, M., S. Coburn, D. Ghosh, L. Simms, L. Giles, D. Yuki, M. Ashley, E. Roemer, H.-O. Sohn, and C. Proctor: Assessment of Priority Tobacco Additives per the Requirements of the EU Tobacco Products Directive (2014/40/EU): Part 3, Smoking Behavior and Plasma Nicotine Pharmacokinetics; Regul. Toxicol. Pharmacol. 104 (2019) 29–38. DOI: 10.1016/j.yrtph.2019.02.012
- St.Charles, F.K., J. McAughey, and C.J. Shepperd: Methodologies for the Quantitative Estimation of Toxicant Dose to Cigarette Smokers Using Physical, Chemical and Bioanalytical Data; Inhal. Toxicol. 25 (2013) 383–397. DOI: 10.3109/08958378.2013.794177
- Scherer, G., J. Mütze, N. Pluym, and M. Scherer: Assessment of Nicotine Delivery and Uptake in Users of Various Tobacco/Nicotine Products; Curr. Res. Toxicol. 3 (2022) 100067. DOI: 10.1016/j.crtox.2022.100067
- St.Charles, F.K., G.R. Krautter, M. Dixon, and D.C. Mariner: A Comparison of Nicotine Dose Estimates in Smokers between Filter Analysis, Salivary Cotinine, and Urinary Excretion of Nicotine Metabolites; Psychopharmacology 189 (2006) 345–354. DOI: 10.1007/s00213-006-0586-x
- Gale, N., M. McEwan, G. Hardie, C.J. Proctor, and J. Murphy: Changes in Biomarkers of Exposure and Biomarkers of Potential Harm after 360 days in Smokers Who Either Continue to Smoke, Switch to a Tobacco Heating Product or Quit Smoking; Intern. Emerg. Med. 17 (2022) 2017–2030. DOI: 10.1007/s11739-022-03062-1
- Kosmider, L., A. Jackson, N. Leigh, R. O'Connor, and M.L. Goniewicz: Circadian Puffing Behavior and Topography among E-Cigarette Users; Tobacco Regulatory Science 4 (2018) 41–49. DOI: 10.18001/trs.4.5.4